drugset
Drugs / SA 14-14-2 Japanese encephalitis vaccine
last change Oct 2008 re-read 3 minutes ago

SA 14-14-2 Japanese encephalitis vaccine

also known as LJEV

Vaccine

Developed for
Japanese encephalitis
Investigated by
Mahidol University · Ministry of Health, Sri Lanka · PATH · Quintiles Singapore

Trials 1

today NCT00463684 · Ph 4
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00463684 Jul → Nov 2007 Japanese encephalitis PATH Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SA 14-14-2 Japanese encephalitis vaccine “live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV)” NCT00463684 ↗
Known as LJEV “live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV)” NCT00463684 ↗
Modality Vaccine “live attenuated SA 14-14-2 Japanese encephalitis vaccine” NCT00463684 ↗
Route Subcutaneous “Administered subcutaneously in the right brachium.” NCT00463684 ↗